Basic Information
LncRNA/CircRNA Name | circ_100876 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, CCK-8, transwell and clone formation assays |
Sample | breast cancer tissues and cell lines |
Expression Pattern | up-regulated |
Function Description | circRNA_100876 level in BC tissues was conspicuously higher than that in the adjacent tissues, and the patients with distant metastasis had higher expression than those without. Moreover, patients with a high expression of circRNA_100876 had a relatively lower overall survival rate. Compared with the NC group, the cell proliferation and invasion ability of circRNA_100876 knockdown group was conspicuously decreased. |
Pubmed ID | 31486496 |
Year | 2019 |
Title | CircRNA_100876 Promote Proliferation and Metastasis of Breast Cancer Cells Through Adsorbing microRNA-361-3p in a Sponge Form |
External Links
Links for circ_100876 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |